Wells Fargo Maintains Equal-Weight on Biogen, Raises Price Target to $190

Benzinga · 1d ago
Wells Fargo analyst Mohit Bansal maintains Biogen (NASDAQ:BIIB) with a Equal-Weight and raises the price target from $155 to $190.